Julie Hamburg is the Director of Patient Advocacy for Guardant Health, a precision oncology company. Prior to joining Guardant, Julie spent 15 years at Pfizer Inc., where she worked across sales, marketing, and corporate affairs. Most notably, she managed outreach and operations for Pfizer’s patient assistance programs for the uninsured and underinsured. It was there that she focused on improving health equity and addressing patients’ affordability and prescription access challenges.
Throughout her career, Julie has worked to amplify the patient voice and advocate for their needs. In 2017, that work became personal, when Julie’s daughter, Lila, was diagnosed with SATB2-associated syndrome (SAS). Since then, she has advocated on behalf of Lila to provide her with the best life possible. Julie is excited to bring her love of advocacy and communications to the SATB2 Gene Foundation to build further awareness, connections, and support for those impacted by SAS, and to ensure their collective voice is heard.
Julie holds a BA in Psychology from the University of Virginia and a Master’s in Public Health from Columbia University.